What is Postural Orthostatic Tachycardia Syndrome (POTS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 25, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Postural Orthostatic Tachycardia Syndrome (POTS)?

POTS is a chronic autonomic disorder characterized by an excessive heart rate increase of ≥30 bpm (≥40 bpm in adolescents aged 12-19 years) within 10 minutes of standing, occurring without orthostatic hypotension, accompanied by symptoms of orthostatic intolerance that improve when lying down. 1, 2

Core Diagnostic Features

POTS requires all five components to be present simultaneously for at least 3 months 2:

  • Heart rate criteria: Sustained increase of ≥30 bpm within 10 minutes of standing (≥40 bpm for ages 12-19), with standing heart rate often exceeding 120 bpm 1, 2
  • Blood pressure criteria: Explicit absence of orthostatic hypotension (no sustained systolic BP drop ≥20 mmHg or diastolic drop ≥10 mmHg within 3 minutes of standing) 1, 2, 3
  • Symptom profile: Frequent symptoms of orthostatic intolerance during standing that rapidly improve upon returning to supine position 2
  • Duration requirement: Symptoms must persist for at least 3 months (6 months in children per some guidelines) 4, 1
  • Exclusion criteria: Absence of other conditions explaining the tachycardia such as anemia, hyperthyroidism, fever, dehydration, medications, or severe deconditioning 4, 1

Clinical Presentation and Symptoms

The typical POTS patient is a young woman of childbearing age (15-45 years old), with approximately 80% female predominance, often with symptom onset in adolescence. 5, 6

Common symptoms include 1, 2, 5:

  • Cardiovascular: Lightheadedness, palpitations, tremulousness, rapid heartbeat upon standing 1, 2
  • Neurological: Blurred vision, "brain fog," cognitive difficulties, headache 1, 5
  • Physical: Generalized weakness, fatigue, lethargy, exercise intolerance 1, 5
  • Other: Chest pain, gastrointestinal dysfunction, musculoskeletal pain 1, 5

Syncope is rare in POTS and typically occurs only when vasovagal reflex activation is triggered, not from POTS itself. 2

Precipitating Factors and Associated Conditions

POTS onset is typically precipitated by immunological stressors 5, 6:

  • Viral infection (including COVID-19) 4, 5, 6
  • Vaccination 5
  • Trauma, pregnancy, or surgery 5
  • Psychosocial stress 5

POTS may be associated with joint hypermobility syndrome, chronic fatigue syndrome, or severe deconditioning. 4, 2

Pathophysiology

POTS represents a heterogeneous clinical syndrome with multiple underlying pathophysiological mechanisms converging as a final common pathway. 7, 6

Three primary phenotypes have been identified 8:

  • Hyperadrenergic POTS: Excessive norepinephrine production or impaired reuptake leading to sympathetic overactivity 8
  • Neuropathic POTS: Partial sympathetic denervation resulting in impaired vasoconstriction during orthostatic stress 8, 7
  • Hypovolemic POTS: Central hypovolemia with reflex tachycardia, often triggered by dehydration and physical deconditioning 8, 7

Prognosis and Natural History

POTS is not associated with mortality, and approximately 50% of patients spontaneously recover within 1-3 years after diagnosis. 7, 5

The condition significantly impairs health-related quality of life, with many patients experiencing physical deconditioning and reduced exercise capacity 8, 5. However, with proper diagnosis and treatment, many patients improve to some degree over time 7.

Prevalence

The prevalence of POTS ranges between 0.2% and 1.0% in developed countries. 5

References

Guideline

Diagnosing Postural Orthostatic Tachycardia Syndrome (POTS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Postural Orthostatic Tachycardia Syndrome (POTS) Diagnosis and Clinical Presentation

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

POTS Diagnosis and Blood Pressure Characteristics

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Postural tachycardia syndrome - Diagnosis, physiology, and prognosis.

Autonomic neuroscience : basic & clinical, 2018

Related Questions

What is Postural Orthostatic Tachycardia Syndrome (POTS)?
Is a heart rate (HR) increase from 70 beats per minute (bpm) at rest to over 100 bpm with activity, potentially compensatory tachycardia or Postural Orthostatic Tachycardia Syndrome (P.O.T.S.), considering a possible low stroke volume index and maintained cardiac output?
Is Postural Orthostatic Tachycardia Syndrome (POTS) a real medical condition?
What is the best approach to diagnose and manage a 23-year-old female patient presenting with chronic dizziness, chest pain, tachycardia, and syncope, particularly when symptoms are triggered by sugar intake and dehydration, and the patient has a history of breastfeeding and possible Postural Orthostatic Tachycardia Syndrome (POTS)?
What is the approach to testing and treating a 23-year-old female patient presenting with concerns for Postural Orthostatic Tachycardia Syndrome (POTS)?
What is the pathophysiological explanation for high Serum-Ascites Albumin Gradient (SAAG) with high protein ascites in early Budd Chiari disease versus high SAAG with low protein ascites in late Budd Chiari disease?
What are the treatment guidelines for a patient experiencing migraines?
What is the recommended approach for managing Restless Legs Syndrome (RLS) in patients with low iron levels, specifically those with ferritin levels ≤75 ng/mL or transferrin saturation <20%?
Do methotrexate (MTX) or alendronate (bisphosphonate) interfere with levothyroxine (T4) therapy in patients with hypothyroidism?
What is the treatment for a patient with Chronic Kidney Disease (CKD), hypertension, and diabetes?
Can Haldol (haloperidol) be given to a patient with a prolonged QT interval?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.